Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Editorials

Treatment options in obstructive sleep apnea

October 31, 2014

Vivek C. Shah, M.D., Gurpreet Singh, M.D., Pramod Kayathi, M.D., Steven Lippmann, M.D.

Obstructive sleep apnea
Obstructive sleep apnea (OSA) is a sleep-related breathing disorder involving a decrease or a temporary halt in airflow despite an effort to breathe. It occurs during sleep with pharyngeal muscle relaxation, resulting in soft tissue collapse, blocking the upper airway. This results in partial reductions (hypopneas) and/or complete pauses (apneas) in breathing, that last at least 10 seconds. Most apneas continue for up to 30 seconds, but may persist for one minute or longer. This leads to reductions in blood oxygen saturation, with oxygen levels falling as much as 40% or more in severe cases. Most people with OSA snore loudly and frequently, with periods of silence when airflow is compromised; they then emit loud chocking, snorting, or gasping sounds as the airway reopens.This induces disruption of sleep continuity and greatly compromises quality of life. The apnea-hypopnea index (AHI) is an OSA measurement that represents the combined average number of apneas and hypopneas that occur per hour of sleep.1

Non-surgical therapies
The initial therapeutic interventions for patients with mild degrees of OSA include weight loss, changing from back-sleeping to side-or-prone position sleeping, and abstaining from smoking, alcohol, or use of sedating drugs or pharmaceuticals. Continuous positive airway pressure (CPAP) is a prominently prescribed treatment for those with more severe cases of OSA.1 Utilization of a CPAP machine can effectively reduce AHI and improves sleep quality. Unfortunately, however, CPAP regimens suffer from cumbersome discomfort and inadequate adherence to therapy, sometimes resulting in treatment failure. Individuals who are non-adherent to OSA therapy have a 10% increase in mortality at five years.1 Considering other nonsurgical options, there are anterior jaw positioning devices available.2  These are removable, therapeutic oral appliances attaching mandibular teeth to maxillary dentition, and thus, not allowing posterior movement of the jaw during sleep. These jaw positioning devices minimize posterior pharyngeal obstruction by keeping the jaw in an anterior position and are inexpensive and usually well tolerated. When these therapies are ineffective, there are surgical alternatives.

Operative approaches
Surgical procedures of the soft palate to treat OSA initially focused on soft tissue volume reduction.3 The success rate with this approach is not uniformly satisfactory, and postoperative complications can be of concern; yet, in children with adeno-tonsillar hypertrophy, such operative procedures demonstrate efficacy.4 Surgical maxillamandibular advancement procedures maybe safer and effective, especially in non-obese younger people with OSA who require mandibular advancement.3 In successful cases, quality of life evidences considerable improvement. A less invasive procedure is a soft palatal implant that can be an effective, low morbidity option for patients diagnosed with mild to moderate OSA.5   These implants are placed in the upper portion of the soft palate under local anesthesia. They increase rigidity of the soft palate, relieving obstruction and are documented with high satisfaction rates.

A new innovation in OSA treatment is an implanted electrical stimulator.6,7  This small pacemaker-like device is implanted into the upper chest with wires connected to the pharynx. The system senses breathing and stimulates the hypoglossal nerve whenever respiration ceases, resulting in activation of the genioglossus muscle and moving the tongue anteriorly. It opens the airway when it should be and prevents upper airway collapse. Approved by the U.S. Food and Drug Administration for people over age 21 this year, it is a very new procedure.8  This stimulator is associated with possible complications that include infection, local pain, tongue abrasion, headache, dry mouth, and speech dysfunction. Utilization over time should verify the safety and efficacy of this electrical device.

References
1. Kakkar R, Berry R. Positive Airway Pressure Treatment for Obstructive Sleep Apnea Chest. 2007; 132(2): 1057-1072   Doi: 10. 1378/chest.06-2432
2. Nq A, Gotsopoulos H, Derendeliler A, et al. Oral appliance therapy for obstructive sleep apnea. Treat Respir Med: 2005; 4(6): 409-422
3. Holty J, Guilleminault C. Maxilomadibular advancement in treatment of obstructive sleep apnea: a systemetic review and met-analysis. Sleep Med Rev: 2010; (14): 287-297
4. Sedky K, Bennete D, Cavalloh K. Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: meta-analysis. Sleep Med Rev: 2014; 18(4): 349-356
5. Walker R, Levine H, Hopp M, et al. Palatal implants: A new approach for the treatment of obstructive sleep apnea. Otolaryngology-Head and Neck Surgery: 2006; 135: 549-554
6. Kezirian E, Boudewyns A, Eisele D, et al. Electrical stimulation of the hypoglossal nerve in the treatment of the obstructive sleep apnea. Sleep Med Rev: 2009; 792-1087
7. Strollo P, Scoose R, Maurer J, et al. Upper airway stimulation for obstructive sleep apnea.  N Engl J Med: 2014; 370:139-149
8. Carter D. Tiny implant may ease moderate to severe sleep apnea. The Courier-Journal (Louisville, Kentucky newspaper): 2014; October 3: D1-D2

Related Posts

Editorials /

The role of the h-index in academic medicine

Editorials /

A timeless commitment: Reflections on the Hippocratic Oath

Editorials /

Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  

‹ Increased Prevalence of Posttraumatic Stress Disorder in Patients After Transient Ischemic Attack › New concerns about caffeine products

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations
  • Conceptualizing a combat veteran’s suicide death through the stress-diathesis model
  • No evidence of a causal link between glucagon-like peptide-1 receptor agonists and suicidal behavior

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.